Dr. Brad Thompson
Kickshaw Ventures Ltd., CEO
Dr. Thompson is an experienced biotechnology company founder and company executive, currently CEO at Kickshaw Ventures Ltd., and Wyvern Pharmaceuticals Inc., and formerly CEO of Oncolytics Biotech, Inc., from 1999 to 2016 and CEO of Synsorb Biotech from 1994 to 1999. He has served as Chairman, Director and Audit Committee member on a number of other public company (NASDAQ, TSX, CDNX) boards of directors, and private company boards and industry groups (including Chairman and Chairman Emeritus of BIOTECanada). He received his Ph.D. from the University of Western Ontario in the Department of Microbiology and Immunology.
We are researching the longevity effects of full skin regeneration (epidermis, dermis, and subcutaneous layers including dendritic and stem cell progenitor cell populations). We will convey what benefits to lifespan extension can be expected by focusing on regenerating whole organ systems.